Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
  • entries
    661
  • comments
    0
  • views
    2,172

About this blog

Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.

 

The report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates. It features an in-depth analysis, highlighting the capabilities of various service providers engaged in this domain. In addition to other elements, the study includes:

§  A detailed assessment of the current market landscape of companies offering drug repurposing services. 

§  Elaborate profiles of key players that specialize in offering services for the development of repurposed drugs.

§  An analysis of the partnerships that have been established in this domain, in the recent past.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  A detailed analysis of more than 1,700 terminated / withdrawn / suspended clinical studies of the drug candidates.

§  A detailed analysis on the cost saving potential of drug repurposing approaches, as compared to the traditional de novo drug development methods.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

  • Type of Repurposing Approaches

§  Disease-centric approach

§  Target-centric approach

§  Drug-centric approach

  • Therapeutic Area

§  Same Therapeutic Area

§  Different Therapeutic Area

  • Type of Drug Molecule

§  Biologics 

§  Small Molecule

  • Key Geographical Region 

§  North America

§  Europe

§  Asia-Pacific

 

Key companies covered in the report

§  Auxillis Pharma

§  ChemBio Discovery Solutions

§  Excelra

§  GVK Bio

§  Iris Pharma

§  Lantern Pharma

§  PanXome

§  Pharmacelera

§  Physiogenex

§  Smart Pharma

§  Socium

§  SOM Biotech

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html

 

Other Recent Offerings

1.     Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 - 2030

2.     China Biopharmaceutical Contract Manufacturing Market, 2020-2030

3.     Antibody Contract Manufacturing Market, 2020 - 2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

 

Entries in this blog

The proteome profiling services market is projected to be worth USD 16 billion by 2030<<By RootsAnalysis>>

Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise   Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”   The report features an extensive study of the current market landscape and future opportunities assoc

The global, handheld X-ray imaging devices market is projected to be worth over USD 2.8(RootsAnalysis)

The growing realization of the importance of early diagnosis coupled to technical advances in digital radiography, have led to the development and widespread adoption of handheld X-ray scanners, revolutionizing modern diagnostic imaging.   Roots Analysis is pleased to announce the publication of its recent study titled, “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical C

The proteome profiling services market is projected to grow at an annualized rate of ~15%:RootsAnalysis:

Roots Analysis has done a detailed study on Proteome Profiling Services Market, 2020-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Market Insights §  Over 200 players situated across the globe, claim to offer a variety of services fo

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030{Roots}

Roots Analysis has done a detailed study on “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and Others), Device Class (Low-End, Mid-End and High-End), End-Users (Ambulatory Surgical Centers, Diagnostic Imaging Centers, Hospitals, Specialty Clinics and Others), and by Key Geographical Regions (North America, Europe, Asia-Pacific, Middle-East and North Africa, Latin America and Rest of the World): Industry Trends and Global Forecasts, 2020-2030” covering key aspects of

The market is fragmented, featuring the presence of both industry and non-industry players"RootsAnalysis"

With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.   To order this 290+ page report, which features 50+ figures and 100+ tables, please visit this - https://www.rootsanalysis.com/report

Several players are currently engaged in the development / manufacturing of handheld{RootsAnalysis}

The applications of handheld imaging devices in modern healthcare are vast, spanning almost all major medical disciplines, from dentistry to cardiology, covering several internal organs across various parts of the body, such as the chest, and abdomen / gastrointestinal tract. In this context, it is worth mentioning that over the past couple of months, multiple studies have described the use of handheld X-ray devices in diagnosing symptoms of the novel coronavirus infection in patients, worldwide

The “Proteome Profiling Services Market, 2020-2030{RootsAnalysis}

To order this detailed 290+ page report, please visit this - https://www.rootsanalysis.com/reports/proteome-profiling-services.html   Key Inclusions §  A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider (industry and non-industry), year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling (protein identification, protein quantification, p

The “Global Handheld X-Ray Imaging Devices Market by Area of Application: RootsAnalysis:

https://www.rootsanalysis.com/reports/handheld-x-ray-imaging-devices-market.html   Key Inclusions §  An overview of the current market landscape of the handheld X-ray imaging devices, providing information on the status of development (developed and under development), area of application (dental, orthopedic and others), weight of device, size of focal spot, tube voltage, type of battery used (lithium ion and lithium polymer), battery voltage, exposure time, battery efficiency and

The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030:By RootsAnalysis:

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions   London   Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.   Over time, extensive R&D on the potential health benefits of can

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030:By Roots:

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community   Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”   The report features an extensive study of the current market landscape, offering an informed op

The endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030(RootsAnalysis)

So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions   Roots Analysis is pleased to announce the publication of its recent study, titled, Endocannabinoid System Targeted Therapeutics Market, 2020-2030   The report features an extensive study of the current market landscape, offering an informe

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%: By RootsAnalysis:

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market (5th Edition), 2019-2030.” , covering various important aspects of the industry and identifying key future growth opportunities.   To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html   Key Market Insights §  Eminent representatives from

The endocannabinoid system targeted therapeutics market is projected to grow at an annualized rate of ~30%{RootsAnalysis}

Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030 “ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Market Insights §  More than 65 industry players across the world a

Presently, over 240 ADC therapy candidates are being evaluated in clinical<Roots>

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects.   To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this -

More than 65 industry players across the world are presently engaged in evaluating the clinical{Roots}

Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.   To order this 250+ page report, which features 140+ figures

The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030<RootsAnalysis>

https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html   Key Inclusions §  A detailed assessment of the current market landscape of ADCs, providing information on drug developer(s) and technology provider(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target antigen, type of linker, type of payload / warhead / cytotoxin, type of antibody, antibody origin, antibody isoty

The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030<RootsAnalysis>

To order this 250+ page report, which features 140+ figures and 170+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html   Key Inclusions §  A detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topi

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030(Roots)

The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes   Roots Analysis has announced the addition of “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report to its list of offerings.   According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by

The next generation immune checkpoint inhibitors and stimulators market is estimated to be worth USD 12.5:Roots:

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions   Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.”   The report features an extensive study of the current market landscape,

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030(RootsAnalysis)

Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic. These portable, pocket-friendly, point-of-care devices have revolutionized the treatment of COVID-19 patients by provide remote access to doctors and ensures

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~15%{Roots}

Roots Analysis has done a detailed study on Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 350+ page report, which features 140+ figures and 170+ tables, please visit this link   Key Market Insights §  More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next g

The global handheld ultrasound imaging devices market is projected to be over{Roots}

Roots Analysis has done a detailed study on “Global Handheld Ultrasound Imaging Devices Market, 2020-2030”” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.   To order this 235+ page report, which features 95+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/handheld-imaging-devices/319.html   Key Market Insights §  Several players are currently engaged in the developm

More than 150 industry players across the world are presently engaged in evaluating<RootsAnalysis>

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and B7-H3) and stimulatory receptors (OX40, ICOS, GITR, 4-1BB and CD40), which are being investigated as potential targets for therapy development. Further, studies of combinatorial immune checkpoint blockade / co-stimulation, targeting newly identified checkpoints along with known checkpoint inhibitor therapies, have demonstrated promising cli

Several players are currently engaged in the development / manufacturing over 100 point-of-care{RootsAnalysis}

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in patients suffering from the novel coronavirus (COVID-19).   To order this 235+ page report, which feat

The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030(RootsAnalysis)

To order this detailed 350+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html   Key Inclusions §  A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory),  type of therapeutic moda
×
  • Create New...